Jitender Madan

Dr. Jitender Madan


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DNDeepa Nakmode
Deepa Nakmode
VBValamla Bhavana
Valamla Bhavana
PTPradip Thakor
Pradip Thakor
JMJitender Madan
Jitender Madan
PSPankaj Kumar Singh
Pankaj Kumar Singh
NMNeelesh Mehra
Neelesh Mehra
Poor aqueous solubility of drugs is still a foremost challenge in pharmaceutical product development. The use of lipids in designing formulations provides an opportunity to enhance the aqueous solubility and consequently bioavailability of drugs. Pre-dissolution of drugs in lipids, surfactants, or mixtures of lipid excipients and surfactants eliminate the dissolution/dissolving step, which is likely to be the rate-limiting factor for oral absorption of poorly water-soluble drugs. In this review, we exhaustively summarize the lipids excipients in relation to their classification, absorption mechanisms, and lipid-based product development. Methodologies utilized for the preparation of solid and semi-solid lipid formulations, applications, phase behaviour, and regulatory perspective of lipid excipients are discussed.

1 May 2015 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
KJKiran Jyoti
Kiran Jyoti
KKKaranvir Kaur
Karanvir Kaur
RPRavi Shankar Pandey
Ravi Shankar Pandey
UJUpendra Kumar Jain
Upendra Kumar Jain
RCRamesh Chandra
Ramesh Chandra
JMJitender Madan
Jitender Madan

1 February 2015 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
NDNishu Dixit
Nishu Dixit
Kumar VaibhavKumar Vaibhav
Kumar Vaibhav
RPRavi Shankar Pandey
Ravi Shankar Pandey
UJUpendra Kumar Jain
Upendra Kumar Jain
OKOm Prakash Katare
Om Prakash Katare
JMJitender Madan
Jitender Madan

1 December 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
KJKiran Jyoti
Kiran Jyoti
RBRicha Kaur Bhatia
Richa Kaur Bhatia
EMElvis Martis
Elvis Martis
ECEvans C. Coutinho
Evans C. Coutinho
UJUpendra Kumar Jain
Upendra Kumar Jain
JMJitender Madan
Jitender Madan

1 July 2013 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JMJitender Madan
Jitender Madan
RPRavi S. Pandey
Ravi S. Pandey
UJUpendra Kumar Jain
Upendra Kumar Jain
OKOm P. Katare
Om P. Katare
RARitu Aneja
Ritu Aneja
AKAnju Katyal
Anju Katyal

27 July 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PRPratheeksha Koppa Raghu
Pratheeksha Koppa Raghu
Kuldeep BansalKuldeep Bansal
Kuldeep Bansal
PTPradip Thakor
Pradip Thakor
VBValamla Bhavana
Valamla Bhavana
JMJitender Madan
Jitender Madan
NMNeelesh Mehra
Neelesh Mehra
The topical route is the most preferred one for administering drugs to eyes, skin and wounds for reaching enhanced efficacy and to improve patient compliance. Topical administration of drugs via conventional dosage forms such as solutions, creams and so forth to the eyes is associated with very low bioavailability (less than 5%) and hence, we cannot rely on these for delivering drugs to eyes more efficiently. An intravitreal injection is another popular drug delivery regime but is associated with complications like intravitreal hemorrhage, retinal detachment, endophthalmitis, and cataracts. The skin has a complex structure that serves as numerous physiological barriers to the entry of exogenous substances. Drug localization is an important aspect of some dermal diseases and requires directed delivery of the active substance to the diseased cells, which is challenging with current approaches. Existing therapies used for wound healing are costly, and they involve long-lasting treatments with 70% chance of recurrence of ulcers. Nanotechnology is a novel and highly potential technology for designing formulations that would improve the efficiency of delivering drugs via the topical route. This review involves a discussion about how nanotechnology-driven drug delivery systems have evolved, and their potential in overcoming the natural barriers for delivering drugs to eyes, skin and wounds.